Study Evaluating ABCL635 for Vasomotor Symptoms of Menopause | MicrobiomeTrials← Back to trialsNCT07118891
Study Evaluating ABCL635 for Vasomotor Symptoms of Menopause
RecruitingPHASE1, PHASE2INTERVENTIONAL
Trial Details
Start: 2025-06-23Est. Completion: 2027-02
Enrollment target: 136 participants Locations- CaRe Clinics, Calgary, Alberta, Canada
- CaRe Clinics, Red Deer, Alberta, Canada
- Mount Saint Joseph Hospital Clinical Trials Phase 1 Unit, Vancouver, British Columbia, Canada
- Centricity Research, Toronto, Ontario, Canada
- Centricity Research, Toronto, Ontario, Canada
- Alpha Recherche Clinique, Lévis, Quebec, Canada
- GCP Research, Montreal, Quebec, Canada
- Altasciences Company Inc., Mount Royal, Quebec, Canada
- Clinique RSF Inc., Québec, Quebec, Canada
- Diex Recherche Québec, Québec, Quebec, Canada
- Diex Recherche Sherbrooke, Sherbrooke, Quebec, Canada
- Diex Recherche Trois-Rivières, Trois-Rivières, Quebec, Canada
- Diex Recherche Victoriaville, Victoriaville, Quebec, Canada
Other microbiome trials you might be interested in
HealthyPerimenopausal DepressionMenopausal ComplaintsBone Mineral DensitySarcopeniaSleep QualityQuality of Life
The goal of this observational study is to learn about the multidimensional determinants of functional health in women a…
Istanbul, Turkey (Türkiye)Completed Dec 31, 2026
Vasomotor Symptoms
This Phase 2a randomized, double-blind, placebo-controlled study evaluates the safety and efficacy of asimadoline (TP005…
Atlanta, United States
Est. completion Oct 31, 2027